Back to Treatments

Treatment

Medroxyprogesterone Acetate (MPA) / Megestrol Acetate (Hormonal Therapy)

1
Conditions
40
Trials
5,000
Participants
60%
Average Safety

Condition Evidence

Uterine cancer

40 trials · 5,000 participants

35% effectiveness · 60% safety
Medroxyprogesterone Acetate (MPA) / Megestrol Acetate (Hormonal Therapy) | DFDA